Home | Market Signals | Green Stocks with Most Upside to Analyst Target Price | New Green AI Signals | Breaking Out | Big Tech Stocks | Solar Stocks | Chip Stocks | Airline Stocks | Social Media Stocks | Oil Stocks| Discount Store Stocks | Entertainment Stocks | EV Stocks | Restaurant Stocks | Heavy Equipment Stocks | Aerospace Stocks | Home Builders | Bank Stock Signals | Cruise Ship Stock Signals

How to Read and Trade AI Powered Stock Charts
Enter Stock Symbol to View AI powered Stock Chart


All Chart Prices as of Previous Day Close

Before accessing this site, you agree that you have read and agree to the disclaimers at the bottom of this page.

Last Price: 194.54 - Change: 5.24 - Change %: 2.7681
12/07/2023 16:00:00 EST

Insulet Corporation (PODD)

Industry: Medical Devices

Price Support Resistance

In the past 30 trading days, PODD has been trading in a range between $187.95 and $127.77 (gray range band). Red lines on the chart represent key resistance levels and Green lines represent key support levels. As the price moves above the lines you will notice they turn green and red if price moves below a line.

PODD is trading between resistance at $223.89 about 15% to the upside and support at $167.38 -14% to the downside. If it can break above the resistance, it could have some more upside to the next line of resistance at $285.53, about a 47% move. If the price starts to turn down and fails to get through this level or enters a yellow zone, we would consider profit taking or exiting the position. If it enters a red zone on the chart we would exit the position.

Upside / Downside Potential

Insulet Corporation (PODD) entered a Green zone 18 days ago on the AI powered stock chart. Wall Street analysts have a recent rating of 4.273, which is a Strong Buy. The current analyst target price is $257.94, which gives it a potential upside of 32.59 % from the recent price of 194.54. The stock is trading 72.67% (potential upside) below its 52 week high of $335.91 and 54.62 % (potential downside) above its 52 week low of $125.82 - based on the recent price.

Company Summary

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia.

PODD Website


Integra Gains From New Product Launches, Mounting Costs Ail
Integra expands the international reach of the CUSA platform and registers DuraGen, DuraSeal, Mayfield and Duo LED lighting in the EMEA and Latin America.
Source: Zacks Investment Research
Tue, 05 Dec 2023 09:46:08 -0500
Sentiment: Positive
Top 5 Momentum Picks for December After Rejuvenated November
Five momentum stocks for December are: NVDA, VRT, CPRT, CEG, PODD.
Source: Zacks Investment Research
Mon, 04 Dec 2023 09:02:13 -0500
Sentiment: Neutral
4 Best Stocks to Invest in for Solid Earnings Growth
Invest in stocks such as Insulet (PODD), W.R. Berkley (WRB), Invitation Home (INVH) and VICI Properties (VICI) for superb earnings growth.
Source: Zacks Investment Research
Mon, 04 Dec 2023 07:31:27 -0500
Sentiment: Positive
Salesforce, Insulet, and Datadog Are November's Top Performers—and These Are the Worst
Salesforce is the Dow Jones Industrial Average's top-performing stock in November, while Cisco is the worst.
Source: Barrons
Thu, 30 Nov 2023 12:43:00 -0500
Sentiment: Positive
Insulet to Present at Upcoming Investor Conferences
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management will present at two upcoming investor conferences (all Eastern Time): The Nasdaq 29th Investor Conference in London on Tuesday, December 5, 2023 at 10:00 a.m. The J.P. Morgan Annual Healthcare Conference in San Francisco on Tuesday, January 9, 2024 at 12:45 p.m. To listen to the live audio webcasts.
Source: Business Wire
Tue, 28 Nov 2023 06:00:00 -0500
Sentiment: Neutral
Instituions Institution %: 106.401
Last QTR Institution change: -1336307

Insiders %: 0.417
Insiders Purchases last QTR: 5551
Insiders Sales last QTR: 84719
Insiders Net last QTR: -79168

Analyst Ratings
Target Price: 257.94
Overall Rating: 4.2727
Strong Buys (5): 12
Buys (4): 4
Holds (3): 6
Sells (2): 0
Strong Sells (1): 0

52 Week Hi: 335.91
52 Week Low: 125.82
Beta: 0.984
50 Day MA: 158.2988
200 Day MA: 244.6025

Earnings / Revenue Trends
Qtr Earnings Growth YOY: -0.15
Qtr Revenue Growth YOY: 0.27
Forward PE: 81.3008
Trailing PE: 110.0581

Benefits of StockChartsAI.com System:

  • Get a Daily List of Stocks Starting New Trends
  • Upload Your Stocks to Quickly See and Track Signals
  • Easy to Understand AI Stock Signals
  • Analysis of Historical Signal Trend Analysis for each stock
  • Search/View AI Stock Signals of Russel 1000 Stocks
  • Easy to Understand AI Stock Signals
  • And MUCH MUCH more!


Stock Analyzed Each Night


Easily Upload Track Your Stocks


See Lists of Stocks Starting New Trends

The information contained on this website is solely for educational purposes, and does not constitute investment advice. The risk of trading in securities markets can be substantial. By accessing this site, you agree we are not liable, whether in contract, tort (including negligence) or otherwise, in respect of any damage, expense or other loss you may suffer arising out of such information or any reliance you may place upon such information from this site. Stocks, Futures and options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the stock, futures and options markets. Don't trade with money you can't afford to lose. This website is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this website. The past performance of any trading system or methodology is not necessarily indicative of future results. Individual results may vary, and testimonials are not claimed to represent typical results. All testimonials are by real people, and may not reflect the typical purchaser’s experience, and are not intended to represent or guarantee that anyone will achieve the same or similar results. HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY, SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.